Friday, 3 February 2017


Torrent Pharmaceuticals Limited has declared an interim dividend of Rs 10 per share to its equity shareholders. Torrent Pharmaceuticals Limited has also declared its Q3FY17 results wherein the net profits stand at Rs 229 cr. Its total income stands at Rs 1443 cr.

The EBITDA stands at Rs 316 cr; whereas the EBITDA margin is reported at 21.9%.

Torrent Pharma is a flagship company of Torrent Group. It is a strong player in the therapeutic areas of cardiovascular (CV) and central nervous system (CNS) functionalities, and has achieved strong presence in the anti-infective, pain management, gastro-intestinal & diabetology segments. 

Torrent Pharmaceuticals Ltd is currently trading at Rs 1315.2, up by Rs 26.3 or 2.04% from its previous closing of Rs 1288.9 on the BSE.

The scrip opened at Rs 1289.05 and has touched a high and low of Rs 1358.95 and Rs 1286.45 respectively. So far 604405(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs 21810.77 crore.

The BSE group 'A' stock of face value Rs 5 has touched a 52 week high of Rs 1767.8 on 25-Aug-2016 and a 52 week low of Rs 1185.6 on 09-Nov-2016. Last one week high and low of the scrip stood at Rs 1326.25 and Rs 1266.05 respectively.

The promoters holding in the company stood at 71.25 % while Institutions and Non-Institutions held 17.76 % and 10.99 % respectively. The stock is currently trading below its 200 DMA.

For Quick Trial – 8962000225 ✔
or mail us here: info@ways2capital.com
✆ - 0731-6626222 | Toll Free - 1800-3010-2007
Give a Missed Call for Free Trial - 09699997717

0 comments: